Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
BLCO
)
14.65
-0.59 (-3.87%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
4
5
Next >
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting
October 26, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1
October 16, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting
October 04, 2023
From
Bausch + Lomb
Via
Business Wire
6 Analysts Have This to Say About Bausch & Lomb
October 03, 2023
Via
Benzinga
Earnings Preview: Bausch & Lomb
August 01, 2023
Via
Benzinga
Analyst Ratings for Bausch & Lomb
July 24, 2023
Via
Benzinga
Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift
October 03, 2023
Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy...
Via
Benzinga
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
September 29, 2023
Via
ACCESSWIRE
Bausch + Lomb Completes Acquisition of XIIDRA®
September 29, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United States
September 26, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Analyst Ratings for Bausch & Lomb
July 03, 2023
Via
Benzinga
Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners
September 20, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Pricing of Senior Secured Notes Offering
September 14, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States
September 12, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R)
September 11, 2023
Via
ACCESSWIRE
Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA®
September 11, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
September 08, 2023
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
COVID-19
Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA®
September 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting
September 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference
August 29, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA®
August 24, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook
August 02, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Solidifies Leadership Team
August 01, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2
July 11, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink
July 06, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC)...
Via
Benzinga
Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops
July 06, 2023
From
Bausch + Lomb Corporation
Via
Business Wire
Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday
June 30, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories
June 30, 2023
New York Post
Via
Benzinga
Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis
June 30, 2023
Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:
Via
Benzinga
Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R)
June 30, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.